High debt and stretched receivables
Consolidated debt stands at ~₹960 crore, with receivables growing 45% YoY due to longer credit periods in emerging markets, straining cash flow.
high · analyst_question
Indoco Remedies Limited — Q4 FY26
Indoco Remedies reported a strong Q4 FY26 with consolidated revenue of ₹456 crore, up 18.8% YoY, driven by a 94.6% surge in international formulations, particularly in regulated...
bullish
medium
✓ Verified against BSE filing
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
Unresolved sterile plant issue
The sterile plant at Pataganda remains unresolved, limiting future US approvals and requiring ongoing investment without immediate returns.
high · management_commentaryExchange rate volatility on ECB loan
A €10 million ECB loan caused a ₹24 crore exchange loss in Q4, impacting finance costs; further currency fluctuations could hurt profitability.
medium · analyst_questionDomestic business seasonality risk
Domestic formulation revenue declined 6% YoY due to weak seasonal demand for anti-infectives and respiratory products, with recovery uncertain.
medium · data_observation